{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "07",
                "@timestamp": "2023-08-07T23:43:30.000030-04:00",
                "@year": "2023",
                "@month": "08"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Merck & Co."},
                {
                    "xocs:funding-agency-matched-string": "Merck Sharp & Dohme LLC",
                    "xocs:funding-agency-acronym": "MSD",
                    "xocs:funding-agency": "Merck Sharp and Dohme",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100009947",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-06-23T06:54:13.242Z",
            "xocs:funding-text": [
                {"$": "Funding for our study was provided by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ. The funder had a role in study design, collection, analysis and interpretation of data and medical writing support. The funder maintained the study database."},
                {"$": "The authors thank the patients and their families and all investigators and site personnel. Medical writing assistance was provided by Yue Liu of Merck & Co., Inc., Rahway, NJ."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60129180",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Shanghai Pulmonary Hospital"},
                                {"$": "Tongji University School of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60129180",
                                    "@dptid": "126644018"
                                },
                                {"@afid": "60073648"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947930321-d01fd4d31e59a7af900753e5ec1e455f-1",
                            "ce:source-text": "Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China",
                            "@dptid": "126644018"
                        },
                        "author": [
                            {
                                "ce:given-name": "Shengxiang",
                                "preferred-name": {
                                    "ce:given-name": "Shengxiang",
                                    "ce:initials": "S.",
                                    "ce:surname": "Ren",
                                    "ce:indexed-name": "Ren S."
                                },
                                "@author-instance-id": "OB2BibRecID-947930321-94803a6dd647cfaac323ac0c8c3aaa5a-1",
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ren",
                                "@auid": "12805882700",
                                "ce:indexed-name": "Ren S."
                            },
                            {
                                "ce:given-name": "Caicun",
                                "preferred-name": {
                                    "ce:given-name": "Caicun",
                                    "ce:initials": "C.",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou C."
                                },
                                "@author-instance-id": "OB2BibRecID-947930321-0977cfacb00b09a9e24c3b842e4925c7-1",
                                "@seq": "20",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Zhou",
                                "@auid": "57225866638",
                                "@orcid": "0000-0002-6958-0766",
                                "ce:indexed-name": "Zhou C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60073601",
                            "@country": "chn",
                            "city": "Nanjing",
                            "organization": [
                                {"$": "Oncology Department"},
                                {"$": "Jiangsu Cancer Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60073601",
                                "@dptid": "104930308"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947930321-81742989912c5f9f9b6b94b2204ed985-1",
                            "ce:source-text": "Oncology Department, Jiangsu Cancer Hospital, Nanjing, China",
                            "@dptid": "104930308"
                        },
                        "author": [{
                            "ce:given-name": "Jifeng",
                            "preferred-name": {
                                "ce:given-name": "Jifeng",
                                "ce:initials": "J.",
                                "ce:surname": "Feng",
                                "ce:indexed-name": "Feng J."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-95eb6cd4a3011f0ac75e8f37fc62e2ca-1",
                            "@seq": "2",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Feng",
                            "@auid": "57212465721",
                            "ce:indexed-name": "Feng J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60029310",
                            "@country": "chn",
                            "city": "Zhejiang",
                            "organization": [
                                {"$": "Department of Thoracic Oncology"},
                                {"$": "Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province"},
                                {"$": "Affiliated Hangzhou First People's Hospital"},
                                {"$": "Zhejiang University School of Medicine"},
                                {"$": "Zhejiang University Cancer Center"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60029310",
                                    "@dptid": "122753298"
                                },
                                {"@afid": "60003970"},
                                {"@afid": "60073538"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947930321-28234f29249bde8834cadd4438ae8b78-1",
                            "ce:source-text": "Department of Thoracic Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Zhejiang University Cancer Center, Zhejiang, People's Republic of China",
                            "@dptid": "122753298"
                        },
                        "author": [{
                            "ce:given-name": "Shenglin",
                            "preferred-name": {
                                "ce:given-name": "Shenglin",
                                "ce:initials": "S.",
                                "ce:surname": "Ma",
                                "ce:indexed-name": "Ma S."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-89fd5b1fa16123d91e0cad0accf95610-1",
                            "@seq": "3",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ma",
                            "@auid": "16230874500",
                            "@orcid": "0000-0003-2851-8875",
                            "ce:indexed-name": "Ma S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60069718",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Guangdong Provincial People's Hospital"},
                                {"$": "Guangdong Lung Cancer Institute"}
                            ],
                            "affiliation-id": {"@afid": "60069718"},
                            "@affiliation-instance-id": "OB2BibRecID-947930321-d3f62e4e2ee0583d0b8e225219ddff55-1",
                            "ce:source-text": "Guangdong Provincial People's Hospital, Guangdong Lung Cancer Institute, Guangzhou, China"
                        },
                        "author": [{
                            "ce:given-name": "HuaJun",
                            "preferred-name": {
                                "ce:given-name": "Hua Jun",
                                "ce:initials": "H.J.",
                                "ce:surname": "Chen",
                                "ce:indexed-name": "Chen H.J."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-085e015a72393b02df7f8a8f030b65b0-1",
                            "@seq": "4",
                            "ce:initials": "H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chen",
                            "@auid": "57140953000",
                            "ce:indexed-name": "Chen H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60018554",
                            "@country": "chn",
                            "city": "Zhengzhou",
                            "organization": [
                                {"$": "Medical Oncology"},
                                {"$": "The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital"}
                            ],
                            "affiliation-id": {"@afid": "60018554"},
                            "@affiliation-instance-id": "OB2BibRecID-947930321-300b61cb2914947f5205731cfeea13ed-1",
                            "ce:source-text": "Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China"
                        },
                        "author": [{
                            "ce:given-name": "Zhiyong",
                            "preferred-name": {
                                "ce:given-name": "Zhiyong",
                                "ce:initials": "Z.",
                                "ce:surname": "Ma",
                                "ce:indexed-name": "Ma Z."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-710cb4773248fd118e45e518d3c8d964-1",
                            "@seq": "5",
                            "ce:initials": "Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ma",
                            "@auid": "57193317360",
                            "ce:indexed-name": "Ma Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "121483016",
                            "@country": "chn",
                            "city": "Fuzhou",
                            "organization": [
                                {"$": "Department of Pneumology"},
                                {"$": "Fujian Provincial Cancer Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "121483016",
                                "@dptid": "129647811"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947930321-a4b81900ff8aadbb4f98f0f2c3637dc1-1",
                            "ce:source-text": "Department of Pneumology, Fujian Provincial Cancer Hospital, Fuzhou, China",
                            "@dptid": "129647811"
                        },
                        "author": [{
                            "ce:given-name": "Cheng",
                            "preferred-name": {
                                "ce:given-name": "Cheng",
                                "ce:initials": "C.",
                                "ce:surname": "Huang",
                                "ce:indexed-name": "Huang C."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-8d3fbc7765eb397e8433cbbc4216caed-1",
                            "@seq": "6",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Huang",
                            "@auid": "55731266200",
                            "ce:indexed-name": "Huang C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60021182",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Cancer Center"},
                                {"$": "Sun Yat-Sen University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60021182"},
                                {"@afid": "60082502"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947930321-d65274b45bf4cd7ae6dbd0875f972608-1",
                            "ce:source-text": "Cancer Center, Sun Yat-Sen University, Guangzhou, China"
                        },
                        "author": [{
                            "ce:given-name": "Li",
                            "preferred-name": {
                                "ce:given-name": "Li",
                                "ce:initials": "L.",
                                "ce:surname": "Zhang",
                                "ce:indexed-name": "Zhang L."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-5f6004dbbb709dc9fd425c1adda47023-1",
                            "@seq": "7",
                            "ce:initials": "L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zhang",
                            "@auid": "57221583840",
                            "ce:indexed-name": "Zhang L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60013156",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Department of Thoracic Surgery"},
                                {"$": "The First Affiliated Hospital of Guangzhou Medical University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60013156",
                                "@dptid": "103691044"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947930321-d9d23ce77c3fcdc64cce6c20d13197db-1",
                            "ce:source-text": "Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China",
                            "@dptid": "103691044"
                        },
                        "author": [{
                            "ce:given-name": "Jianxing",
                            "preferred-name": {
                                "ce:given-name": "Jianxing",
                                "ce:initials": "J.",
                                "ce:surname": "He",
                                "ce:indexed-name": "He J."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-5fbce0d5a33c002ab13a83292fe174b0-1",
                            "@seq": "8",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "He",
                            "@auid": "57824617900",
                            "ce:indexed-name": "He J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60017260",
                            "@country": "chn",
                            "city": "Tianjin",
                            "organization": [
                                {"$": "Department of Biotherapy 17F"},
                                {"$": "Tianjin Medical University Cancer Institute & Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60017260",
                                "@dptid": "123430152"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947930321-94b95d584be7984ab7d406797523865e-1",
                            "ce:source-text": "Department of Biotherapy 17F, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China",
                            "@dptid": "123430152"
                        },
                        "author": [{
                            "ce:given-name": "Changli",
                            "preferred-name": {
                                "ce:given-name": "Changli",
                                "ce:initials": "C.",
                                "ce:surname": "Wang",
                                "ce:indexed-name": "Wang C."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-10dd0bc316a3f43d62c8bbe7fa346863-1",
                            "@seq": "9",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wang",
                            "@auid": "57215737853",
                            "ce:indexed-name": "Wang C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60118428",
                            "@country": "chn",
                            "city": "Hangzhou",
                            "organization": [
                                {"$": "Department of Respiratory Medicine"},
                                {"$": "The First Affiliated Hospital of Zhejiang University College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60118428",
                                "@dptid": "122946540"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947930321-6b3bb666473f9ad55d1ba92898b27e26-1",
                            "ce:source-text": "Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China",
                            "@dptid": "122946540"
                        },
                        "author": [{
                            "ce:given-name": "Jianying",
                            "preferred-name": {
                                "ce:given-name": "Jianying",
                                "ce:initials": "J.",
                                "ce:surname": "Zhou",
                                "ce:indexed-name": "Zhou J."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-80ac102602c80d832955cb4363761ba0-1",
                            "@seq": "10",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zhou",
                            "@auid": "56521848700",
                            "ce:indexed-name": "Zhou J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199575",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Siriraj Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60199575",
                                "@dptid": "125771105"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947930321-121a8cf123607ad8dd1037f5cd278647-1",
                            "ce:source-text": "Division of Medical Oncology, Siriraj Hospital, Bangkok, Thailand",
                            "@dptid": "125771105"
                        },
                        "author": [{
                            "ce:given-name": "Pongwut",
                            "preferred-name": {
                                "ce:given-name": "Pongwut",
                                "ce:initials": "P.",
                                "ce:surname": "Danchaivijtr",
                                "ce:indexed-name": "Danchaivijtr P."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-5d89d851c43f4d042154778b99ef7830-1",
                            "@seq": "11",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Danchaivijtr",
                            "@auid": "58235042100",
                            "ce:indexed-name": "Danchaivijtr P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "109593237",
                            "@country": "twn",
                            "city": "Kaohsiung",
                            "organization": {"$": "Chang Gung Medical Foundation"},
                            "affiliation-id": {"@afid": "109593237"},
                            "@affiliation-instance-id": "OB2BibRecID-947930321-922e48770292b7a22032066ec832d8a9-1",
                            "ce:source-text": "Chang Gung Medical Foundation, Kaohsiung, Taiwan"
                        },
                        "author": [{
                            "ce:given-name": "Chin-Chou",
                            "preferred-name": {
                                "ce:given-name": "Chin Chou",
                                "ce:initials": "C.C.",
                                "ce:surname": "Wang",
                                "ce:indexed-name": "Wang C.C."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-5b6fc2278cdce849cd4bb525cb1c1c7c-1",
                            "@seq": "12",
                            "ce:initials": "C.-C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wang",
                            "@auid": "22136891400",
                            "ce:indexed-name": "Wang C.-C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Ukraine",
                            "@afid": "60016511",
                            "@country": "ukr",
                            "city": "Sumy",
                            "organization": [
                                {"$": "RMI Sumy Regional Clinical Oncology Dispensary"},
                                {"$": "Sumy State University"}
                            ],
                            "affiliation-id": {"@afid": "60016511"},
                            "@affiliation-instance-id": "OB2BibRecID-947930321-1dac8c7c0af34d4bae69ee8579abc3d7-1",
                            "ce:source-text": "RMI Sumy Regional Clinical Oncology Dispensary, Sumy State University, Sumy, Ukraine"
                        },
                        "author": [{
                            "ce:given-name": "Ihor",
                            "preferred-name": {
                                "ce:given-name": "Ihor",
                                "ce:initials": "I.",
                                "ce:surname": "Vynnychenko",
                                "ce:indexed-name": "Vynnychenko I."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-aeac38943ee441a1af9a247354568a8e-1",
                            "@seq": "13",
                            "ce:initials": "I.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Vynnychenko",
                            "@auid": "24781268000",
                            "ce:indexed-name": "Vynnychenko I."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60118432",
                            "@country": "chn",
                            "city": "Hangzhou",
                            "organization": [
                                {"$": "Department of Respiration Medicine"},
                                {"$": "The Second Affiliated Hospital of Zhejiang University College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60118432",
                                "@dptid": "122946881"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947930321-d11615ef4924afe2e9faa9b017de77aa-1",
                            "ce:source-text": "Department of Respiration Medicine, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China",
                            "@dptid": "122946881"
                        },
                        "author": [{
                            "ce:given-name": "Kai",
                            "preferred-name": {
                                "ce:given-name": "Kai",
                                "ce:initials": "K.",
                                "ce:surname": "Wang",
                                "ce:indexed-name": "Wang K."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-5ec8b2f5445dbb0b185115a6db3da864-1",
                            "@seq": "14",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wang",
                            "@auid": "57209477039",
                            "ce:indexed-name": "Wang K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Chile",
                            "@afid": "127887073",
                            "@country": "chl",
                            "city": "Providencia",
                            "organization": [
                                {"$": "Region Metropolitana de Santiago"},
                                {"$": "Orlandi Oncologia"}
                            ],
                            "affiliation-id": {"@afid": "127887073"},
                            "@affiliation-instance-id": "OB2BibRecID-947930321-33c0b83f3a3a54ce76f385800ac076e7-1",
                            "ce:source-text": "Region Metropolitana de Santiago, Orlandi Oncologia, Providencia, Chile"
                        },
                        "author": [{
                            "ce:given-name": "Francisco",
                            "preferred-name": {
                                "ce:given-name": "Francisco",
                                "ce:initials": "F.",
                                "ce:surname": "Orlandi",
                                "ce:indexed-name": "Orlandi F."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-c0ceae1173efdb55ced6ead3d752be74-1",
                            "@seq": "15",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Orlandi",
                            "@auid": "57202575919",
                            "ce:indexed-name": "Orlandi F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Medical Oncology Unit"},
                                {"$": "King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60022183",
                                "@dptid": "122312150"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947930321-1e237e0287b76005819e3d183c9a2c76-1",
                            "ce:source-text": "Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "122312150"
                        },
                        "author": [{
                            "ce:given-name": "Virote",
                            "preferred-name": {
                                "ce:given-name": "Virote",
                                "ce:initials": "V.",
                                "ce:surname": "Sriuranpong",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-dd7ce97952c1c32db42ad8807a85a9ea-1",
                            "@seq": "16",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sriuranpong",
                            "@auid": "6603599644",
                            "ce:indexed-name": "Sriuranpong V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "122400614",
                            "@country": "chn",
                            "city": "Beijing",
                            "organization": {"$": "MSD China"},
                            "affiliation-id": {"@afid": "122400614"},
                            "@affiliation-instance-id": "OB2BibRecID-947930321-513f8e9e492f16fdfdad5173a29195e3-1",
                            "ce:source-text": "MSD China, Beijing, China"
                        },
                        "author": [{
                            "ce:given-name": "Ben",
                            "preferred-name": {
                                "ce:given-name": "Ben",
                                "ce:initials": "B.",
                                "ce:surname": "Li",
                                "ce:indexed-name": "Li B."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-0a8650a5bc014d39a3e848fe5020db4e-1",
                            "@seq": "17",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Li",
                            "@auid": "58408331500",
                            "ce:indexed-name": "Li B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "113017334",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": {"$": "MSD China"},
                            "affiliation-id": {"@afid": "113017334"},
                            "@affiliation-instance-id": "OB2BibRecID-947930321-21ae3f766603aeda93b842b65ea646e0-1",
                            "ce:source-text": "MSD China, Shanghai, China"
                        },
                        "author": [{
                            "ce:given-name": "Jun",
                            "preferred-name": {
                                "ce:given-name": "Jun",
                                "ce:initials": "J.",
                                "ce:surname": "Ge",
                                "ce:indexed-name": "Ge J."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-8e28cb3e105c360cdd21fe10fbe8afc1-1",
                            "@seq": "18",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ge",
                            "@auid": "57215651143",
                            "ce:indexed-name": "Ge J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60007995",
                            "@country": "usa",
                            "city": "Rahway",
                            "organization": [
                                {"$": "Merck & Co."},
                                {"$": "Inc."}
                            ],
                            "affiliation-id": {"@afid": "60007995"},
                            "state": "NJ",
                            "@affiliation-instance-id": "OB2BibRecID-947930321-94647cee52f670b7b8cc260e7edc5508-1",
                            "ce:source-text": "Merck & Co., Inc., Rahway, NJ, USA"
                        },
                        "author": [{
                            "ce:given-name": "Thao",
                            "preferred-name": {
                                "ce:given-name": "Thao",
                                "ce:initials": "T.",
                                "ce:surname": "Dang",
                                "ce:indexed-name": "Dang T."
                            },
                            "@author-instance-id": "OB2BibRecID-947930321-f7e79033395fe38c8432500ca9fc238a-1",
                            "@seq": "19",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Dang",
                            "@auid": "57220483227",
                            "ce:indexed-name": "Dang T."
                        }]
                    }
                ],
                "citation-title": "KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC",
                "abstracts": "© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.KEYNOTE-033 (NCT02864394) was a multicountry, open-label, phase 3 study that compared pembrolizumab vs docetaxel in previously treated, programmed death-ligand 1 (PD-L1)-positive, advanced non-small cell lung cancer (NSCLC), with most patients enrolled in mainland China. Eligible patients were randomized (1:1) to pembrolizumab 2 mg/kg or docetaxel 75 mg/m2 every 3 weeks. Primary endpoints were overall survival (OS) and progression-free survival and were evaluated sequentially using stratified log-rank tests, first in patients with PD-L1 tumor proportion score (TPS) ≥50% and then in patients with PD-L1 TPS ≥1% (significance threshold: P <.025, one-sided). A total of 425 patients were randomized to pembrolizumab (N = 213) or docetaxel (N = 212) between 8 September 2016 and 17 October 2018. In patients with a PD-L1 TPS ≥50% (n = 227), median OS was 12.3 months with pembrolizumab and 10.9 months with docetaxel; the hazard ratio (HR) was 0.83 (95% confidence interval [CI]: 0.61-1.14; P =.1276). Because the significance threshold was not met, sequential testing of OS and PFS was ceased. In patients with a PD-L1 TPS ≥1%, the HR for OS for pembrolizumab vs docetaxel was 0.75 (95% CI: 0.60-0.95). In patients from mainland China (n = 311) with a PD-L1 TPS ≥1%, HR for OS was 0.68 (95% CI: 0.51-0.89). Incidence of grade 3 to 5 treatment-related AEs was 11.3% with pembrolizumab vs 47.5% with docetaxel. In summary, pembrolizumab improved OS vs docetaxel in previously treated, PD-L1-positive NSCLC without unexpected safety signals; although the statistical significance threshold was not reached, the numerical improvement is consistent with that previously observed for pembrolizumab in previously treated, advanced NSCLC.",
                "correspondence": {
                    "affiliation": {
                        "country": "China",
                        "address-part": "No. 507 Zhengmin Road",
                        "postal-code": "200 443",
                        "@country": "chn",
                        "city": "Shanghai",
                        "organization": [
                            {"$": "Shanghai Pulmonary Hospital"},
                            {"$": "Tongji University School of Medicine"}
                        ],
                        "@affiliation-instance-id": "OB2BibRecID-947930321-dc227eaf3f009a28f0567cee6752fecf-1",
                        "ce:source-text": "Shanghai Pulmonary Hospital, Tongji University School of Medicine, No. 507 Zhengmin Road, Shanghai, 200 443, China"
                    },
                    "person": {
                        "ce:given-name": "Caicun",
                        "@author-instance-id": "OB2BibRecID-947930321-16d3d37c24dcaee25c476455d3c9ca29-1",
                        "ce:initials": "C.",
                        "ce:surname": "Zhou",
                        "ce:indexed-name": "Zhou C."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "immunotherapy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "NSCLC",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "pembrolizumab",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "programmed death 1",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "programmed death-ligand 1",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "International Journal of Cancer",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "153",
                            "@issue": "3"
                        },
                        "pagerange": {
                            "@first": "623",
                            "@last": "634"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "International Journal of Cancer",
                    "publicationdate": {
                        "month": "08",
                        "year": "2023",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 August 2023"
                        },
                        "day": "01"
                    },
                    "codencode": "IJCNA",
                    "sourcetitle-abbrev": "Int. J. Cancer",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "10970215",
                            "@type": "electronic"
                        },
                        {
                            "$": "00207136",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "John Wiley and Sons Inc"},
                    "@srcid": "29873"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "15",
                                    "classification-description": "Chest Diseases, Thoracic Surgery and Tuberculosis"
                                },
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "114977-28-5",
                                    "chemical-name": "docetaxel"
                                },
                                {
                                    "cas-registry-number": "79079-06-4",
                                    "chemical-name": "epidermal growth factor receptor"
                                },
                                {
                                    "cas-registry-number": "1374853-91-4",
                                    "chemical-name": "pembrolizumab"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "B7-H1 Antigen"},
                                {"chemical-name": "CD274 protein, human"},
                                {"chemical-name": "Docetaxel"},
                                {"chemical-name": "pembrolizumab"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors thank the patients and their families and all investigators and site personnel. Medical writing assistance was provided by Yue Liu of Merck & Co., Inc., Rahway, NJ.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "03",
                    "@timestamp": "BST 13:09:22",
                    "@year": "2023",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2023067001",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "947930321",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230423549",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "37141294",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20231266847",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20231688573",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20239013840293",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85158052515",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85158052515",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "641207651",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76399999",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1002/ijc.34532"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "26",
                "reference": [
                    {
                        "ref-fulltext": "Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249. doi:10.3322/caac.21660",
                        "@reference-instance-id": "OB2BibRecID-947930321-2541d0b2cf1b8e098041fdffacfc3d11-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3322/caac.21660",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100345654",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "71"},
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "249"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Sung",
                                        "ce:indexed-name": "Sung H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferlay",
                                        "ce:indexed-name": "Ferlay J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Siegel",
                                        "ce:indexed-name": "Siegel R.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249. doi:10.3322/caac.21660"
                    },
                    {
                        "ref-fulltext": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. doi:10.3322/caac.21492",
                        "@reference-instance-id": "OB2BibRecID-947930321-438a3a3e4290b72740d0ed07d64eadf0-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3322/caac.21492",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85053395052",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "394",
                                    "@last": "424"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Bray",
                                    "ce:indexed-name": "Bray F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Ferlay",
                                    "ce:indexed-name": "Ferlay J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Soerjomataram",
                                    "ce:indexed-name": "Soerjomataram I."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Siegel",
                                    "ce:indexed-name": "Siegel R.L."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "L.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Torre",
                                    "ce:indexed-name": "Torre L.A."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jemal",
                                    "ce:indexed-name": "Jemal A."
                                }
                            ]},
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. doi:10.3322/caac.21492"
                    },
                    {
                        "ref-fulltext": "American Cancer Society. Non-small cell lung cancer. https://www.cancer.org/cancer/lung-cancer/about/what-is.html. Accessed March 9, 2021",
                        "@reference-instance-id": "OB2BibRecID-947930321-7434a84871243b158115e57a7b1a7c70-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.cancer.org/cancer/lung-cancer/about/what-is.html",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "ijc34532-cit-0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84871351824",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed March 9, 2021",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "American Cancer Society",
                                "ce:indexed-name": "American Cancer Society"
                            }},
                            "ref-sourcetitle": "Non-small cell lung cancer"
                        },
                        "ce:source-text": "American Cancer Society. Non-small cell lung cancer. https://www.cancer.org/cancer/lung-cancer/about/what-is.html. Accessed March 9, 2021"
                    },
                    {
                        "ref-fulltext": "Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346:92-98. doi:10.1056/NEJMoa011954",
                        "@reference-instance-id": "OB2BibRecID-947930321-b01f5ec1cceb3227b1308508541b2760-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa011954",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0037050352",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "346"},
                                "pagerange": {
                                    "@first": "92",
                                    "@last": "98"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Schiller",
                                        "ce:indexed-name": "Schiller J.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Harrington",
                                        "ce:indexed-name": "Harrington D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Belani",
                                        "ce:indexed-name": "Belani C.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346:92-98. doi:10.1056/NEJMoa011954"
                    },
                    {
                        "ref-fulltext": "Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373:123-135. doi:10.1056/NEJMoa1504627",
                        "@reference-instance-id": "OB2BibRecID-947930321-8191e2bdf739a6b1b3197da0e472f731-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1504627",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84936791837",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "373"},
                                "pagerange": {
                                    "@first": "123",
                                    "@last": "135"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Brahmer",
                                        "ce:indexed-name": "Brahmer J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Reckamp",
                                        "ce:indexed-name": "Reckamp K.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Baas",
                                        "ce:indexed-name": "Baas P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373:123-135. doi:10.1056/NEJMoa1504627"
                    },
                    {
                        "ref-fulltext": "Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627-1639. doi:10.1056/NEJMoa1507643",
                        "@reference-instance-id": "OB2BibRecID-947930321-47288fe1fa32b1c1a78802c4c0f6c8a2-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1507643",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84944937210",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "373"},
                                "pagerange": {
                                    "@first": "1627",
                                    "@last": "1639"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Borghaei",
                                        "ce:indexed-name": "Borghaei H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Paz-Ares",
                                        "ce:indexed-name": "Paz-Ares L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Horn",
                                        "ce:indexed-name": "Horn L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627-1639. doi:10.1056/NEJMoa1507643"
                    },
                    {
                        "ref-fulltext": "Garon EB, Rizvi NA, Hui R, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med. 2015;372:2018-2028. doi:10.1056/NEJMoa1501824",
                        "@reference-instance-id": "OB2BibRecID-947930321-c5256500ca36bd8058b4416c3f59ef50-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pembrolizumab for the treatment of non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1501824",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84929481480",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "372"},
                                "pagerange": {
                                    "@first": "2018",
                                    "@last": "2028"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Garon",
                                        "ce:indexed-name": "Garon E.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Rizvi",
                                        "ce:indexed-name": "Rizvi N.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Hui",
                                        "ce:indexed-name": "Hui R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Garon EB, Rizvi NA, Hui R, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med. 2015;372:2018-2028. doi:10.1056/NEJMoa1501824"
                    },
                    {
                        "ref-fulltext": "Herbst RS, Baas P, Kim DW, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387:1540-1550. doi:10.1016/S0140-6736(15)01281-7",
                        "@reference-instance-id": "OB2BibRecID-947930321-70042dc53bb4d0cda33087d91f6b78cf-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(15)01281-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84950117835",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "387"},
                                "pagerange": {
                                    "@first": "1540",
                                    "@last": "1550"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Herbst",
                                        "ce:indexed-name": "Herbst R.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Baas",
                                        "ce:indexed-name": "Baas P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim D.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Herbst RS, Baas P, Kim DW, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387:1540-1550. doi:10.1016/S0140-6736(15)01281-7"
                    },
                    {
                        "ref-fulltext": "Peters S, Kerr KM, Stahel R. PD-1 blockade in advanced NSCLC: a focus on pembrolizumab. Cancer Treat Rev. 2018;62:39-49. doi:10.1016/j.ctrv.2017.10.002",
                        "@reference-instance-id": "OB2BibRecID-947930321-aa93b62df336377457be588a951590b5-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "PD-1 blockade in advanced NSCLC: a focus on pembrolizumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.ctrv.2017.10.002",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85034629880",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "62"},
                                "pagerange": {
                                    "@first": "39",
                                    "@last": "49"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Peters",
                                    "ce:indexed-name": "Peters S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Kerr",
                                    "ce:indexed-name": "Kerr K.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Stahel",
                                    "ce:indexed-name": "Stahel R."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Treat Rev"
                        },
                        "ce:source-text": "Peters S, Kerr KM, Stahel R. PD-1 blockade in advanced NSCLC: a focus on pembrolizumab. Cancer Treat Rev. 2018;62:39-49. doi:10.1016/j.ctrv.2017.10.002"
                    },
                    {
                        "ref-fulltext": "Rittmeyer A, Barlesi F, Waterkamp D, et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet. 2017;389:255-265. doi:10.1016/S0140-6736(16)32517-X",
                        "@reference-instance-id": "OB2BibRecID-947930321-988abb9dd2e14d98e9de1161d365ac33-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(16)32517-X",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85008239423",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "389"},
                                "pagerange": {
                                    "@first": "255",
                                    "@last": "265"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Rittmeyer",
                                        "ce:indexed-name": "Rittmeyer A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Barlesi",
                                        "ce:indexed-name": "Barlesi F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Waterkamp",
                                        "ce:indexed-name": "Waterkamp D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Rittmeyer A, Barlesi F, Waterkamp D, et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet. 2017;389:255-265. doi:10.1016/S0140-6736(16)32517-X"
                    },
                    {
                        "ref-fulltext": "Na Z, Yeo SP, Bharath SR, et al. Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab. Cell Res. 2017;27:147-150. doi:10.1038/cr.2016.77",
                        "@reference-instance-id": "OB2BibRecID-947930321-dd75897d63f3479df37763e112dbd58b-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/cr.2016.77",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84975226255",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "147",
                                    "@last": "150"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Na",
                                        "ce:indexed-name": "Na Z."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Yeo",
                                        "ce:indexed-name": "Yeo S.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Bharath",
                                        "ce:indexed-name": "Bharath S.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell Res"
                        },
                        "ce:source-text": "Na Z, Yeo SP, Bharath SR, et al. Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab. Cell Res. 2017;27:147-150. doi:10.1038/cr.2016.77"
                    },
                    {
                        "ref-fulltext": "Scapin G, Yang X, Prosise WW, et al. Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab. Nat Struct Mol Biol. 2015;22:953-958. doi:10.1038/nsmb.3129",
                        "@reference-instance-id": "OB2BibRecID-947930321-1abad6abd52d2182f36c9e80582658aa-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nsmb.3129",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84949533006",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "953",
                                    "@last": "958"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Scapin",
                                        "ce:indexed-name": "Scapin G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang X."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Prosise",
                                        "ce:indexed-name": "Prosise W.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Struct Mol Biol"
                        },
                        "ce:source-text": "Scapin G, Yang X, Prosise WW, et al. Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab. Nat Struct Mol Biol. 2015;22:953-958. doi:10.1038/nsmb.3129"
                    },
                    {
                        "ref-fulltext": "Chatterjee M, Turner DC, Felip E, et al. Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. Ann Oncol. 2016;27:1291-1298. doi:10.1093/annonc/mdw174",
                        "@reference-instance-id": "OB2BibRecID-947930321-e50797c6d15fbafc9e81de0942e8c027-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdw174",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84977119270",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "1291",
                                    "@last": "1298"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Chatterjee",
                                        "ce:indexed-name": "Chatterjee M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Turner",
                                        "ce:indexed-name": "Turner D.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Felip",
                                        "ce:indexed-name": "Felip E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Chatterjee M, Turner DC, Felip E, et al. Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. Ann Oncol. 2016;27:1291-1298. doi:10.1093/annonc/mdw174"
                    },
                    {
                        "ref-fulltext": "Merck & Co., Inc., Kenilworth, NJ, USA., KEYTRUDA is First Anti-PD-1 Therapy Approved as Monotherapy and in Combination with Chemotherapy in First-Line Setting for NSCLC in China. https://www.merck.com/news/mercks-keytruda-pembrolizumab-now-approved-as-monotherapy-in-china-for-first-line-treatment-of-certain-patients-with-advanced-non-small-cell-lung-cancer-nsclc-whose-tumors-express-p/. Accessed March 9, 2021",
                        "@reference-instance-id": "OB2BibRecID-947930321-d5848981e2f85171701b41d2ad770ea2-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.merck.com/news/mercks-keytruda-pembrolizumab-now-approved-as-monotherapy-in-china-for-first-line-treatment-of-certain-patients-with-advanced-non-small-cell-lung-cancer-nsclc-whose-tumors-express-p/",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "ijc34532-cit-0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85161731981",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Accessed March 9, 2021",
                            "ref-sourcetitle": "Merck & Co., Inc., Kenilworth, NJ, USA., KEYTRUDA is First Anti-PD-1 Therapy Approved as Monotherapy and in Combination with Chemotherapy in First-Line Setting for NSCLC in China"
                        },
                        "ce:source-text": "Merck & Co., Inc., Kenilworth, NJ, USA., KEYTRUDA is First Anti-PD-1 Therapy Approved as Monotherapy and in Combination with Chemotherapy in First-Line Setting for NSCLC in China. https://www.merck.com/news/mercks-keytruda-pembrolizumab-now-approved-as-monotherapy-in-china-for-first-line-treatment-of-certain-patients-with-advanced-non-small-cell-lung-cancer-nsclc-whose-tumors-express-p/. Accessed March 9, 2021"
                    },
                    {
                        "ref-fulltext": "Wu YL, Zhang L, Fan Y, et al. Randomized clinical trial of pembrolizumab versus chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China study. Int J Cancer. 2021;148(9):2313-2320. doi:10.1002/ijc.33399",
                        "@reference-instance-id": "OB2BibRecID-947930321-69034dd157f92139587d9e49116ef94b-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Randomized clinical trial of pembrolizumab versus chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/ijc.33399",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85097318442",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "148",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "2313",
                                    "@last": "2320"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu Y.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Fan",
                                        "ce:indexed-name": "Fan Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Cancer"
                        },
                        "ce:source-text": "Wu YL, Zhang L, Fan Y, et al. Randomized clinical trial of pembrolizumab versus chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China study. Int J Cancer. 2021;148(9):2313-2320. doi:10.1002/ijc.33399"
                    },
                    {
                        "ref-fulltext": "Ma Y, Fang W, Zhang Y, et al. KEYNOTE-032: a randomized phase I study of pembrolizumab in Chinese patients with advanced non-small-cell lung cancer. Oncologist. 2020;25:650. doi:10.1634/theoncologist.2020-0067",
                        "@reference-instance-id": "OB2BibRecID-947930321-77af59c429834c5bf96beb6bab16d732-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "KEYNOTE-032: a randomized phase I study of pembrolizumab in Chinese patients with advanced non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1634/theoncologist.2020-0067",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081602645",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {"@first": "650"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Fang",
                                        "ce:indexed-name": "Fang W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Ma Y, Fang W, Zhang Y, et al. KEYNOTE-032: a randomized phase I study of pembrolizumab in Chinese patients with advanced non-small-cell lung cancer. Oncologist. 2020;25:650. doi:10.1634/theoncologist.2020-0067"
                    },
                    {
                        "ref-fulltext": "Zhou C, Caglevic C, Zhou J, et al. KEYNOTE-033: phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC). Ann Oncol. 2017;28:x143. doi:10.1093/annonc/mdx671.055",
                        "@reference-instance-id": "OB2BibRecID-947930321-837edf51b42467f3fdc3665485ba8923-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "KEYNOTE-033: phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdx671.055",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85091533172",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "28"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Caglevic",
                                        "ce:indexed-name": "Caglevic C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Zhou C, Caglevic C, Zhou J, et al. KEYNOTE-033: phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (NSCLC). Ann Oncol. 2017;28:x143. doi:10.1093/annonc/mdx671.055"
                    },
                    {
                        "ref-fulltext": "Zhou C, Feng J, Ma S, et al. Randomized, open-label phase III study of pembrolizumab (pembro) vs docetaxel (doce) in patients (pts) with previously treated NSCLC with PD-L1 tumour proportion score (TPS) ≥1%: KEYNOTE-033. Ann Oncol. 2020;31:S816. doi:10.1016/j.annonc.2020.08.1576",
                        "@reference-instance-id": "OB2BibRecID-947930321-081d698a29d2b5471159d3217346b0d6-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Randomized, open-label phase III study of pembrolizumab (pembro) vs docetaxel (doce) in patients (pts) with previously treated NSCLC with PD-L1 tumour proportion score (TPS) ≥1%: KEYNOTE-033"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.annonc.2020.08.1576",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85104443063",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "31"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Feng",
                                        "ce:indexed-name": "Feng J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Zhou C, Feng J, Ma S, et al. Randomized, open-label phase III study of pembrolizumab (pembro) vs docetaxel (doce) in patients (pts) with previously treated NSCLC with PD-L1 tumour proportion score (TPS) ≥1%: KEYNOTE-033. Ann Oncol. 2020;31:S816. doi:10.1016/j.annonc.2020.08.1576"
                    },
                    {
                        "ref-fulltext": "Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-247. doi:10.1016/j.ejca.2008.10.026",
                        "@reference-instance-id": "OB2BibRecID-947930321-e263bf42288a4d3607d4aa390f6b22d6-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.ejca.2008.10.026",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "57849117384",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "228",
                                    "@last": "247"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Eisenhauer",
                                        "ce:indexed-name": "Eisenhauer E.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Therasse",
                                        "ce:indexed-name": "Therasse P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bogaerts",
                                        "ce:indexed-name": "Bogaerts J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-247. doi:10.1016/j.ejca.2008.10.026"
                    },
                    {
                        "ref-fulltext": "Barlesi F, Vansteenkiste J, Spigel D, et al. Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN lung 200): an open-label, randomised, phase 3 study. Lancet Oncol. 2018;19:1468-1479. doi:10.1016/S1470-2045(18)30673-9",
                        "@reference-instance-id": "OB2BibRecID-947930321-31793619070fa312d07aeed272b609f3-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN lung 200): an open-label, randomised, phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(18)30673-9",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057183840",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "1468",
                                    "@last": "1479"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Barlesi",
                                        "ce:indexed-name": "Barlesi F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Vansteenkiste",
                                        "ce:indexed-name": "Vansteenkiste J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Spigel",
                                        "ce:indexed-name": "Spigel D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Barlesi F, Vansteenkiste J, Spigel D, et al. Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN lung 200): an open-label, randomised, phase 3 study. Lancet Oncol. 2018;19:1468-1479. doi:10.1016/S1470-2045(18)30673-9"
                    },
                    {
                        "ref-fulltext": "Solomon BJ, Mok T, Kim DW, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014;371:2167-2177. doi:10.1056/NEJMoa1408440",
                        "@reference-instance-id": "OB2BibRecID-947930321-1088f81020ab4f91a7fca49b4497a285-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "First-line crizotinib versus chemotherapy in ALK-positive lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1408440",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84918804764",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "371"},
                                "pagerange": {
                                    "@first": "2167",
                                    "@last": "2177"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Solomon",
                                        "ce:indexed-name": "Solomon B.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim D.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Solomon BJ, Mok T, Kim DW, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014;371:2167-2177. doi:10.1056/NEJMoa1408440"
                    },
                    {
                        "ref-fulltext": "Roach C, Zhang N, Corigliano E, et al. Development of a companion diagnostic PD-L1 immunohistochemistry assay for pembrolizumab therapy in non-small-cell lung cancer. Appl Immunohistochem Mol Morphol. 2016;24:392-397. doi:10.1097/PAI.0000000000000408",
                        "@reference-instance-id": "OB2BibRecID-947930321-ceae0e95bb2b54957c79109b1f86449e-22",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Development of a companion diagnostic PD-L1 immunohistochemistry assay for pembrolizumab therapy in non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/PAI.0000000000000408",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84975493654",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "392",
                                    "@last": "397"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Roach",
                                        "ce:indexed-name": "Roach C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Corigliano",
                                        "ce:indexed-name": "Corigliano E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Appl Immunohistochem Mol Morphol"
                        },
                        "ce:source-text": "Roach C, Zhang N, Corigliano E, et al. Development of a companion diagnostic PD-L1 immunohistochemistry assay for pembrolizumab therapy in non-small-cell lung cancer. Appl Immunohistochem Mol Morphol. 2016;24:392-397. doi:10.1097/PAI.0000000000000408"
                    },
                    {
                        "ref-fulltext": "Apetoh L, Ladoire S, Coukos G, Ghiringhelli F. Combining immunotherapy and anticancer agents: the right path to achieve cancer cure? Ann Oncol. 2015;26:1813-1823. doi:10.1093/annonc/mdv209",
                        "@reference-instance-id": "OB2BibRecID-947930321-e882fe3d8be00e7ad8b9976dec5aef6f-23",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdv209",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84937246543",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "1813",
                                    "@last": "1823"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Apetoh",
                                    "ce:indexed-name": "Apetoh L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Ladoire",
                                    "ce:indexed-name": "Ladoire S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Coukos",
                                    "ce:indexed-name": "Coukos G."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Ghiringhelli",
                                    "ce:indexed-name": "Ghiringhelli F."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Apetoh L, Ladoire S, Coukos G, Ghiringhelli F. Combining immunotherapy and anticancer agents: the right path to achieve cancer cure? Ann Oncol. 2015;26:1813-1823. doi:10.1093/annonc/mdv209"
                    },
                    {
                        "ref-fulltext": "Sorensen SF, Zhou W, Dolled-Filhart M, et al. PD-L1 expression and survival among patients with advanced non-small cell lung cancer treated with chemotherapy. Transl Oncol. 2016;9:64-69. doi:10.1016/j.tranon.2016.01.003",
                        "@reference-instance-id": "OB2BibRecID-947930321-f86ceb3e5a30436fdea840ccabeab57d-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "PD-L1 expression and survival among patients with advanced non-small cell lung cancer treated with chemotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.tranon.2016.01.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84974691152",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "64",
                                    "@last": "69"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Sorensen",
                                        "ce:indexed-name": "Sorensen S.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Dolled-Filhart",
                                        "ce:indexed-name": "Dolled-Filhart M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transl Oncol"
                        },
                        "ce:source-text": "Sorensen SF, Zhou W, Dolled-Filhart M, et al. PD-L1 expression and survival among patients with advanced non-small cell lung cancer treated with chemotherapy. Transl Oncol. 2016;9:64-69. doi:10.1016/j.tranon.2016.01.003"
                    },
                    {
                        "ref-fulltext": "Wu YL, Lu S, Cheng Y, et al. Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced NSCLC: CheckMate 078 randomized phase III clinical trial. J Thorac Oncol. 2019;14:867-875. doi:10.1016/j.jtho.2019.01.006",
                        "@reference-instance-id": "OB2BibRecID-947930321-47de2a6a3b6f84cb1da9d9d425691265-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced NSCLC: CheckMate 078 randomized phase III clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jtho.2019.01.006",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85061626989",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "867",
                                    "@last": "875"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu Y.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Cheng",
                                        "ce:indexed-name": "Cheng Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "Wu YL, Lu S, Cheng Y, et al. Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced NSCLC: CheckMate 078 randomized phase III clinical trial. J Thorac Oncol. 2019;14:867-875. doi:10.1016/j.jtho.2019.01.006"
                    },
                    {
                        "ref-fulltext": "Fehrenbacher L, Spira A, Ballinger M, et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet. 2016;387:1837-1846. doi:10.1016/S0140-6736(16)00587-0",
                        "@reference-instance-id": "OB2BibRecID-947930321-2dd27bfe7e22c2e70519c4dc50aa08cf-26",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(16)00587-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "ijc34532-cit-0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84962038946",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "387"},
                                "pagerange": {
                                    "@first": "1837",
                                    "@last": "1846"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Fehrenbacher",
                                        "ce:indexed-name": "Fehrenbacher L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Spira",
                                        "ce:indexed-name": "Spira A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Ballinger",
                                        "ce:indexed-name": "Ballinger M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Fehrenbacher L, Spira A, Ballinger M, et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet. 2016;387:1837-1846. doi:10.1016/S0140-6736(16)00587-0"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60129180",
            "affilname": "Tongji University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60129180",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Hangzhou",
            "@id": "60118432",
            "affilname": "The Second Affiliated Hospital Zhejiang University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118432",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Hangzhou",
            "@id": "60118428",
            "affilname": "The First Affiliated Hospital, Zhejiang University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118428",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Nanjing",
            "@id": "60073601",
            "affilname": "Jiangsu Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073601",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60069718",
            "affilname": "Guangdong Provincial People\u2019s Hospital of Southern Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069718",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Hangzhou",
            "@id": "60029310",
            "affilname": "Zhejiang University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029310",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60021182",
            "affilname": "Sun Yat-Sen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021182",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Zhengzhou",
            "@id": "60018554",
            "affilname": "Zhengzhou University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018554",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Tianjin",
            "@id": "60017260",
            "affilname": "Tianjin Medical University Cancer Institute &amp; Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017260",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Sumy",
            "@id": "60016511",
            "affilname": "Sumy State University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016511",
            "affiliation-country": "Ukraine"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60013156",
            "affilname": "Guangzhou Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013156",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Rahway",
            "@id": "60007995",
            "affilname": "Merck &amp; Co., Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Providencia",
            "@id": "127887073",
            "affilname": "Orlandi Oncologia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127887073",
            "affiliation-country": "Chile"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "122400614",
            "affilname": "MSD China",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122400614",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Fuzhou",
            "@id": "121483016",
            "affilname": "Fujian Provincial Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/121483016",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "113017334",
            "affilname": "MSD China",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113017334",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kaohsiung",
            "@id": "109593237",
            "affilname": "Chang Gung Medical Foundation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109593237",
            "affiliation-country": "Taiwan"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85158052515",
        "dc:description": "KEYNOTE-033 (NCT02864394) was a multicountry, open-label, phase 3 study that compared pembrolizumab vs docetaxel in previously treated, programmed death-ligand 1 (PD-L1)-positive, advanced non-small cell lung cancer (NSCLC), with most patients enrolled in mainland China. Eligible patients were randomized (1:1) to pembrolizumab 2 mg/kg or docetaxel 75 mg/m2 every 3 weeks. Primary endpoints were overall survival (OS) and progression-free survival and were evaluated sequentially using stratified log-rank tests, first in patients with PD-L1 tumor proportion score (TPS) ≥50% and then in patients with PD-L1 TPS ≥1% (significance threshold: P <.025, one-sided). A total of 425 patients were randomized to pembrolizumab (N = 213) or docetaxel (N = 212) between 8 September 2016 and 17 October 2018. In patients with a PD-L1 TPS ≥50% (n = 227), median OS was 12.3 months with pembrolizumab and 10.9 months with docetaxel; the hazard ratio (HR) was 0.83 (95% confidence interval [CI]: 0.61-1.14; P =.1276). Because the significance threshold was not met, sequential testing of OS and PFS was ceased. In patients with a PD-L1 TPS ≥1%, the HR for OS for pembrolizumab vs docetaxel was 0.75 (95% CI: 0.60-0.95). In patients from mainland China (n = 311) with a PD-L1 TPS ≥1%, HR for OS was 0.68 (95% CI: 0.51-0.89). Incidence of grade 3 to 5 treatment-related AEs was 11.3% with pembrolizumab vs 47.5% with docetaxel. In summary, pembrolizumab improved OS vs docetaxel in previously treated, PD-L1-positive NSCLC without unexpected safety signals; although the statistical significance threshold was not reached, the numerical improvement is consistent with that previously observed for pembrolizumab in previously treated, advanced NSCLC.",
        "pubmed-id": "37141294",
        "prism:coverDate": "2023-08-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85158052515",
        "dc:creator": {"author": [{
            "ce:given-name": "Shengxiang",
            "preferred-name": {
                "ce:given-name": "Shengxiang",
                "ce:initials": "S.",
                "ce:surname": "Ren",
                "ce:indexed-name": "Ren S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60129180",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60129180"
            },
            "ce:surname": "Ren",
            "@auid": "12805882700",
            "author-url": "https://api.elsevier.com/content/author/author_id/12805882700",
            "ce:indexed-name": "Ren S."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85158052515"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85158052515&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85158052515&origin=inward"
            }
        ],
        "source-id": "29873",
        "citedby-count": "2",
        "prism:volume": "153",
        "subtype": "ar",
        "dc:title": "KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC",
        "openaccess": "1",
        "prism:issn": "10970215 00207136",
        "publishercopyright": "© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "International Journal of Cancer",
        "prism:pageRange": "623-634",
        "prism:endingPage": "634",
        "openaccessFlag": "true",
        "prism:doi": "10.1002/ijc.34532",
        "prism:startingPage": "623",
        "dc:identifier": "SCOPUS_ID:85158052515",
        "dc:publisher": "John Wiley and Sons Inc"
    },
    "idxterms": {"mainterm": [
        {
            "$": "B7-H1 Antigen",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Carcinoma, Non-Small-Cell Lung",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Docetaxel",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lung Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "immunotherapy"
        },
        {
            "@_fa": "true",
            "$": "NSCLC"
        },
        {
            "@_fa": "true",
            "$": "pembrolizumab"
        },
        {
            "@_fa": "true",
            "$": "programmed death 1"
        },
        {
            "@_fa": "true",
            "$": "programmed death-ligand 1"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Shengxiang",
            "preferred-name": {
                "ce:given-name": "Shengxiang",
                "ce:initials": "S.",
                "ce:surname": "Ren",
                "ce:indexed-name": "Ren S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60129180",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60129180"
            },
            "ce:surname": "Ren",
            "@auid": "12805882700",
            "author-url": "https://api.elsevier.com/content/author/author_id/12805882700",
            "ce:indexed-name": "Ren S."
        },
        {
            "ce:given-name": "Jifeng",
            "preferred-name": {
                "ce:given-name": "Jifeng",
                "ce:initials": "J.",
                "ce:surname": "Feng",
                "ce:indexed-name": "Feng J."
            },
            "@seq": "2",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073601",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073601"
            },
            "ce:surname": "Feng",
            "@auid": "57212465721",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212465721",
            "ce:indexed-name": "Feng J."
        },
        {
            "ce:given-name": "Shenglin",
            "preferred-name": {
                "ce:given-name": "Shenglin",
                "ce:initials": "S.",
                "ce:surname": "Ma",
                "ce:indexed-name": "Ma S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029310",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029310"
            },
            "ce:surname": "Ma",
            "@auid": "16230874500",
            "author-url": "https://api.elsevier.com/content/author/author_id/16230874500",
            "ce:indexed-name": "Ma S."
        },
        {
            "ce:given-name": "HuaJun",
            "preferred-name": {
                "ce:given-name": "Hua Jun",
                "ce:initials": "H.J.",
                "ce:surname": "Chen",
                "ce:indexed-name": "Chen H.J."
            },
            "@seq": "4",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60069718",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069718"
            },
            "ce:surname": "Chen",
            "@auid": "57140953000",
            "author-url": "https://api.elsevier.com/content/author/author_id/57140953000",
            "ce:indexed-name": "Chen H."
        },
        {
            "ce:given-name": "Zhiyong",
            "preferred-name": {
                "ce:given-name": "Zhiyong",
                "ce:initials": "Z.",
                "ce:surname": "Ma",
                "ce:indexed-name": "Ma Z."
            },
            "@seq": "5",
            "ce:initials": "Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018554",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018554"
            },
            "ce:surname": "Ma",
            "@auid": "57193317360",
            "author-url": "https://api.elsevier.com/content/author/author_id/57193317360",
            "ce:indexed-name": "Ma Z."
        },
        {
            "ce:given-name": "Cheng",
            "preferred-name": {
                "ce:given-name": "Cheng",
                "ce:initials": "C.",
                "ce:surname": "Huang",
                "ce:indexed-name": "Huang C."
            },
            "@seq": "6",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "121483016",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/121483016"
            },
            "ce:surname": "Huang",
            "@auid": "55731266200",
            "author-url": "https://api.elsevier.com/content/author/author_id/55731266200",
            "ce:indexed-name": "Huang C."
        },
        {
            "ce:given-name": "Li",
            "preferred-name": {
                "ce:given-name": "Li",
                "ce:initials": "L.",
                "ce:surname": "Zhang",
                "ce:indexed-name": "Zhang L."
            },
            "@seq": "7",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60021182",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021182"
            },
            "ce:surname": "Zhang",
            "@auid": "57221583840",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221583840",
            "ce:indexed-name": "Zhang L."
        },
        {
            "ce:given-name": "Jianxing",
            "preferred-name": {
                "ce:given-name": "Jianxing",
                "ce:initials": "J.",
                "ce:surname": "He",
                "ce:indexed-name": "He J."
            },
            "@seq": "8",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60013156",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013156"
            },
            "ce:surname": "He",
            "@auid": "57824617900",
            "author-url": "https://api.elsevier.com/content/author/author_id/57824617900",
            "ce:indexed-name": "He J."
        },
        {
            "ce:given-name": "Changli",
            "preferred-name": {
                "ce:given-name": "Changli",
                "ce:initials": "C.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang C."
            },
            "@seq": "9",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017260",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017260"
            },
            "ce:surname": "Wang",
            "@auid": "57215737853",
            "author-url": "https://api.elsevier.com/content/author/author_id/57215737853",
            "ce:indexed-name": "Wang C."
        },
        {
            "ce:given-name": "Jianying",
            "preferred-name": {
                "ce:given-name": "Jianying",
                "ce:initials": "J.",
                "ce:surname": "Zhou",
                "ce:indexed-name": "Zhou J."
            },
            "@seq": "10",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60118428",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118428"
            },
            "ce:surname": "Zhou",
            "@auid": "56521848700",
            "author-url": "https://api.elsevier.com/content/author/author_id/56521848700",
            "ce:indexed-name": "Zhou J."
        },
        {
            "ce:given-name": "Pongwut",
            "preferred-name": {
                "ce:given-name": "Pongwut",
                "ce:initials": "P.",
                "ce:surname": "Danchaivijtr",
                "ce:indexed-name": "Danchaivijtr P."
            },
            "@seq": "11",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:surname": "Danchaivijtr",
            "@auid": "58235042100",
            "author-url": "https://api.elsevier.com/content/author/author_id/58235042100",
            "ce:indexed-name": "Danchaivijtr P."
        },
        {
            "ce:given-name": "Chin-Chou",
            "preferred-name": {
                "ce:given-name": "Chin Chou",
                "ce:initials": "C.C.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang C.C."
            },
            "@seq": "12",
            "ce:initials": "C.-C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "109593237",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109593237"
            },
            "ce:surname": "Wang",
            "@auid": "22136891400",
            "author-url": "https://api.elsevier.com/content/author/author_id/22136891400",
            "ce:indexed-name": "Wang C.-C."
        },
        {
            "ce:given-name": "Ihor",
            "preferred-name": {
                "ce:given-name": "Ihor",
                "ce:initials": "I.",
                "ce:surname": "Vynnychenko",
                "ce:indexed-name": "Vynnychenko I."
            },
            "@seq": "13",
            "ce:initials": "I.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016511",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016511"
            },
            "ce:surname": "Vynnychenko",
            "@auid": "24781268000",
            "author-url": "https://api.elsevier.com/content/author/author_id/24781268000",
            "ce:indexed-name": "Vynnychenko I."
        },
        {
            "ce:given-name": "Kai",
            "preferred-name": {
                "ce:given-name": "Kai",
                "ce:initials": "K.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang K."
            },
            "@seq": "14",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60118432",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118432"
            },
            "ce:surname": "Wang",
            "@auid": "57209477039",
            "author-url": "https://api.elsevier.com/content/author/author_id/57209477039",
            "ce:indexed-name": "Wang K."
        },
        {
            "ce:given-name": "Francisco",
            "preferred-name": {
                "ce:given-name": "Francisco",
                "ce:initials": "F.",
                "ce:surname": "Orlandi",
                "ce:indexed-name": "Orlandi F."
            },
            "@seq": "15",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "127887073",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127887073"
            },
            "ce:surname": "Orlandi",
            "@auid": "57202575919",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202575919",
            "ce:indexed-name": "Orlandi F."
        },
        {
            "ce:given-name": "Virote",
            "preferred-name": {
                "ce:given-name": "Virote",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "16",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "ce:given-name": "Ben",
            "preferred-name": {
                "ce:given-name": "Ben",
                "ce:initials": "B.",
                "ce:surname": "Li",
                "ce:indexed-name": "Li B."
            },
            "@seq": "17",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122400614",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122400614"
            },
            "ce:surname": "Li",
            "@auid": "58408331500",
            "author-url": "https://api.elsevier.com/content/author/author_id/58408331500",
            "ce:indexed-name": "Li B."
        },
        {
            "ce:given-name": "Jun",
            "preferred-name": {
                "ce:given-name": "Jun",
                "ce:initials": "J.",
                "ce:surname": "Ge",
                "ce:indexed-name": "Ge J."
            },
            "@seq": "18",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "113017334",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113017334"
            },
            "ce:surname": "Ge",
            "@auid": "57215651143",
            "author-url": "https://api.elsevier.com/content/author/author_id/57215651143",
            "ce:indexed-name": "Ge J."
        },
        {
            "ce:given-name": "Thao",
            "preferred-name": {
                "ce:given-name": "Thao",
                "ce:initials": "T.",
                "ce:surname": "Dang",
                "ce:indexed-name": "Dang T."
            },
            "@seq": "19",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60007995",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007995"
            },
            "ce:surname": "Dang",
            "@auid": "57220483227",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220483227",
            "ce:indexed-name": "Dang T."
        },
        {
            "ce:given-name": "Caicun",
            "preferred-name": {
                "ce:given-name": "Caicun",
                "ce:initials": "C.",
                "ce:surname": "Zhou",
                "ce:indexed-name": "Zhou C."
            },
            "@seq": "20",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60129180",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60129180"
            },
            "ce:surname": "Zhou",
            "@auid": "57225866638",
            "author-url": "https://api.elsevier.com/content/author/author_id/57225866638",
            "ce:indexed-name": "Zhou C."
        }
    ]}
}}